Shionogi & Co. Ltd.’s share price plunged in morning trading in Tokyo on 23 June following a surprise decision the previous day from an advisory panel considering the emergency approval of its oral COVID-19 drug Xocova (ensitrelvir; S-217622).
The Japanese firm’s stock initially dropped around 10% following the meeting of the committee, which advises the Ministry of Health...







